低分子APIの世界市場レポート 2025年

低分子APIの市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR7.9％で2,964億7,000万米ドルに成長します。予測期間の成長は、サプライチェーンの強靭化、医薬品製造のデジタル化、オンコロジーへの投資の増加、グリーンケミストリーの採用、パンデミックによるヘルスケアのニーズなどに起因すると考えられます。予測期間における主な動向としては、バイオ医薬品シナジー、個別化医療、高度な製造技術、APIアウトソーシング、受託製造などが挙げられます。

低分子医薬品に対する需要の増加は、低分子API市場の成長を促進すると予想されます。低分子医薬品は、病気の診断、治療、予防のために生化学的プロセスに影響を与えることができる低分子化合物です。低分子医薬品の例としては、アスピリンやジフェンヒドラミンなどがあり、薬箱によく入っています。これらの医薬品は低分子APIに分類され、病気の予防に貢献しています。例えば、米国政府部門である計画・評価担当次官補室の2023年12月の報告書によると、2022年、単一メーカーが製造する低分子医薬品は低分子医薬品市場全体の43％を占めるが、その市場全体の支出の65％を占めています。このように、低分子医薬品に対する需要の高まりが低分子API市場の成長を後押ししています。

慢性疾患の有病率の上昇は、今後数年間、低分子API市場の成長を促進すると予測されています。慢性疾患とは、3カ月以上持続し、時間の経過とともに悪化する病気を指します。心血管系疾患、糖尿病、がんなどの治療には継続的な投薬が必要であり、その結果、医薬品治療に対する一貫した需要が生じる。低分子APIは、最適化されたバイオアベイラビリティ、改善された薬物動態、最小限の副作用を提供し、慢性疾患の長期治療計画の全体的な有効性と患者の受容性を高める薬剤の調合に不可欠です。例えば、2023年1月、米国の国立医学図書館である国立生物工学情報センター（NCBI）は、世界の慢性疾患患者数が2022年の7,152万2,000人から2050年には1億4,266万人に達する見込みであると報告しました。したがって、慢性疾患の有病率の増加が低分子API市場の成長に拍車をかけています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の低分子APIPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の低分子API市場：成長率分析
• 世界の低分子API市場の実績：規模と成長, 2019-2024
• 世界の低分子API市場の予測：規模と成長, 2024-2029, 2034F
• 世界の低分子API総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の低分子API市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 合成
• バイオテクノロジー
• 世界の低分子API市場：製造別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 社内
• アウトソーシング
• 世界の低分子API市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 心臓病学
• 腫瘍学
• 中枢神経系と神経学
• 整形外科
• 内分泌学
• その他の用途
• 世界の低分子API市場：合成のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 化学合成
• プロセス開発
• カスタム合成
• 世界の低分子API市場：バイオテクノロジーのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 組み換えタンパク質
• モノクローナル抗体
• ペプチド

第7章 地域別・国別分析

• 世界の低分子API市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の低分子API市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 低分子API市場：競合情勢
• 低分子API市場：企業プロファイル
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
  • Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis
  • Dr. Reddy's Laboratories Ltd. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Aurobindo Pharma
• Sun Pharmaceutical Industries Ltd.
• Teva Pharmaceutical Industries Ltd.
• Viatris Inc.
• Cambrex Corporation
• Lonza Group AG
• Siegfried Holding AG
• AstraZeneca
• F. Hoffmann-La Roche AG
• Nanjing King-friend Biochemical Pharmaceutical Co. Ltd
• Albany Molecular Research Inc.
• BASF SE
• Gilead Sciences Inc.
• GlaxoSmithKline PLC
• Johnson Matthey PLC

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 低分子API市場2029：新たな機会を提供する国
• 低分子API市場2029：新たな機会を提供するセグメント
• 低分子API市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Small molecules API (active pharmaceutical ingredients) are organic compounds characterized by their low molecular weight, typically less than 1 nanometer and comprised of 20-100 atoms. These active ingredients play a pivotal role in various biological and pharmaceutical processes, serving as fundamental components. Small molecules APIs find extensive applications in both pharmaceutical and biological procedures, aiding in the exploration of biological functions and contributing to the development of novel therapeutic agents.

The primary categories of small molecule APIs encompass synthetic and biotech variations. Synthetic small molecule APIs are created within laboratory settings through diverse chemical processes. Manufacturing of these small molecule APIs can occur in-house or through outsourced means, catering to multiple applications such as cardiology, oncology, CNS and neurology, orthopaedics, endocrinology, and various other medical fields.

The small molecule API market research report is one of a series of new reports from The Business Research Company that provides small molecule API market statistics, including small molecule API industry global market size, regional shares, competitors with a small molecule API market share, detailed small molecule API market segments, market trends and opportunities, and any further data you may need to thrive in the small molecule API industry. This small molecule API market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The small molecule api market size has grown strongly in recent years. It will grow from $204.47 billion in 2024 to $218.35 billion in 2025 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to rise of generic drug manufacturing, increased R&D investment, aging population demands, expansion in oncology treatments, emergence of targeted therapies.

The small molecule api market size is expected to see strong growth in the next few years. It will grow to $296.47 billion in 2029 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to supply chain resilience, digitalization in pharmaceutical manufacturing, increasing investment in oncology, adoption of green chemistry, pandemic-driven healthcare needs. Major trends in the forecast period include biopharmaceutical synergy, personalized medicine, advanced manufacturing techniques, API outsourcing and contract manufacturing.

The increasing demand for small-molecule drugs is anticipated to drive the growth of the small-molecule API market. Small-molecule drugs are low-molecular-weight compounds that can influence biochemical processes to diagnose, treat, or prevent diseases. Examples of small-molecule drugs include aspirin and diphenhydramine, which are commonly found in medicine cabinets. These drug products fall under the category of small-molecule API products, contributing to disease prevention. For instance, a report from December 2023 by the Office of the Assistant Secretary for Planning and Evaluation, a U.S. government department, indicated that in 2022, small-molecule drugs produced by a single manufacturer accounted for 43% of the total small-molecule drug market but represented 65% of the overall expenditures in that market. Thus, the rising demand for small-molecule drugs is propelling the growth of the small-molecule API market.

The rising prevalence of chronic diseases is projected to drive the growth of the small molecules API market in the coming years. Chronic diseases refer to illnesses that persist for three months or longer and can worsen over time. Conditions such as cardiovascular diseases, diabetes, and cancer require ongoing medication, resulting in a consistent demand for pharmaceutical treatments. Small molecules APIs are essential in formulating drugs that offer optimized bioavailability, improved pharmacokinetics, and minimized side effects, enhancing the overall effectiveness and patient acceptability of long-term treatment plans for chronic illnesses. For example, in January 2023, the National Center for Biotechnology Information (NCBI), a US-based National Library of Medicine, reported that the number of people with chronic diseases worldwide is expected to reach 142.66 million by 2050, up from 71.522 million in 2022. Therefore, the increasing prevalence of chronic diseases is fueling the growth of the small molecule API market.

A notable trend in the small-molecule API market is the emphasis on strategic partnerships. Many companies in the market are actively engaging in partnerships to strengthen their market positions and advance the development of drugs and therapies. For instance, in March 2023, CatSci Ltd., a UK-based pharmaceutical company, partnered with AGC Pharma Chemicals, a Spain-based pharmaceutical company, to enhance drug development. This collaboration leverages CatSci's non-clinical expertise with AGC's manufacturing capabilities, particularly supporting clinical phase projects. The partnership aims to provide strategic value, expedite drug development timelines, and deliver impactful small-molecule API-based medicines globally. This trend underscores the significance of collaborative efforts in driving innovation and growth within the small-molecule API market.

Major companies in the small molecules API market are actively developing new technologies to address solubility challenges, particularly for oral small molecules. In March 2022, Evonik Industries AG, a leading Germany-based specialty chemicals company, introduced EUDRATEC SoluFlow. This microparticle technology is specifically designed to enhance the solubility of active pharmaceutical ingredients (APIs) in oral drugs. EUDRATEC SoluFlow employs an emulsion-based process to overcome solubility challenges for over 70% of new small molecules. The technology facilitates the development of oral therapeutics in critical medical areas by transforming poorly soluble drugs into easily processed amorphous solid dispersions (ASD). Notably, this innovation reduces post-processing complexity, offering a significant advancement in addressing solubility issues for oral small molecules.

In a strategic move, GHO Capital, a European specialist investor in healthcare companies, made a noteworthy acquisition in March 2022 by securing a majority stake in Sterling Pharma Solutions. This acquisition positions GHO Capital to leverage extensive pharmaceutical expertise in Europe and expand its market presence in the United States. Sterling Pharma Solutions, a US-based manufacturer specializing in active pharmaceutical ingredients (APIs), aligns with GHO Capital's strategic objectives in the healthcare sector. This move underscores the significance of strategic investments and partnerships in driving growth and innovation within the small molecules API market.

Major companies operating in the small molecule api market are Merck & Co. Inc., AbbVie Inc., Bristol-Myers Squibb Company, Boehringer Ingelheim International GmbH, Dr. Reddy's Laboratories Ltd., Aurobindo Pharma, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc., Cambrex Corporation, Lonza Group AG, Siegfried Holding AG, AstraZeneca, F. Hoffmann-La Roche AG, Nanjing King-friend Biochemical Pharmaceutical Co. Ltd, Albany Molecular Research Inc., BASF SE, Gilead Sciences Inc., GlaxoSmithKline PLC, Johnson Matthey PLC, Novartis AG

North America was the largest region in the small molecule API market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the small molecule api market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the small molecule api market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The small molecules API market consists of sales of contract and captive small molecules API. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Small Molecule API Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on small molecule api market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for small molecule api ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The small molecule api market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Synthetic; Biotech
• 2) By Manufacturer: In-House; Outsourced
• 3) By Application: Cardiology; Oncology; CNS And Neurology; Orthopedic; Endocrinology; Other Applications
• Subsegments:
• 1) By Synthetic: Chemical Synthesis; Process Development; Custom Synthesis
• 2) By Biotech: Recombinant Proteins; Monoclonal Antibodies; Peptides
• Companies Mentioned: Merck & Co. Inc.; AbbVie Inc.; Bristol-Myers Squibb Company; Boehringer Ingelheim International GmbH; Dr. Reddy's Laboratories Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Small Molecule API Market Characteristics

3. Small Molecule API Market Trends And Strategies

4. Small Molecule API Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Small Molecule API Growth Analysis And Strategic Analysis Framework

• 5.1. Global Small Molecule API PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Small Molecule API Market Growth Rate Analysis
• 5.4. Global Small Molecule API Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Small Molecule API Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Small Molecule API Total Addressable Market (TAM)

6. Small Molecule API Market Segmentation

• 6.1. Global Small Molecule API Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Synthetic
• Biotech
• 6.2. Global Small Molecule API Market, Segmentation By Manufacturer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• In-House
• Outsourced
• 6.3. Global Small Molecule API Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cardiology
• Oncology
• CNS And Neurology
• Orthopedic
• Endocrinology
• Other Applications
• 6.4. Global Small Molecule API Market, Sub-Segmentation Of Synthetic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chemical Synthesis
• Process Development
• Custom Synthesis
• 6.5. Global Small Molecule API Market, Sub-Segmentation Of Biotech, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Recombinant Proteins
• Monoclonal Antibodies
• Peptides

7. Small Molecule API Market Regional And Country Analysis

• 7.1. Global Small Molecule API Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Small Molecule API Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Small Molecule API Market

• 8.1. Asia-Pacific Small Molecule API Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Small Molecule API Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Small Molecule API Market, Segmentation By Manufacturer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Small Molecule API Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Small Molecule API Market

• 9.1. China Small Molecule API Market Overview
• 9.2. China Small Molecule API Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Small Molecule API Market, Segmentation By Manufacturer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Small Molecule API Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Small Molecule API Market

• 10.1. India Small Molecule API Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Small Molecule API Market, Segmentation By Manufacturer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Small Molecule API Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Small Molecule API Market

• 11.1. Japan Small Molecule API Market Overview
• 11.2. Japan Small Molecule API Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Small Molecule API Market, Segmentation By Manufacturer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Small Molecule API Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Small Molecule API Market

• 12.1. Australia Small Molecule API Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Small Molecule API Market, Segmentation By Manufacturer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Small Molecule API Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Small Molecule API Market

• 13.1. Indonesia Small Molecule API Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Small Molecule API Market, Segmentation By Manufacturer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Small Molecule API Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Small Molecule API Market

• 14.1. South Korea Small Molecule API Market Overview
• 14.2. South Korea Small Molecule API Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Small Molecule API Market, Segmentation By Manufacturer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Small Molecule API Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Small Molecule API Market

• 15.1. Western Europe Small Molecule API Market Overview
• 15.2. Western Europe Small Molecule API Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Small Molecule API Market, Segmentation By Manufacturer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Small Molecule API Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Small Molecule API Market

• 16.1. UK Small Molecule API Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Small Molecule API Market, Segmentation By Manufacturer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Small Molecule API Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Small Molecule API Market

• 17.1. Germany Small Molecule API Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Small Molecule API Market, Segmentation By Manufacturer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Small Molecule API Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Small Molecule API Market

• 18.1. France Small Molecule API Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Small Molecule API Market, Segmentation By Manufacturer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Small Molecule API Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Small Molecule API Market

• 19.1. Italy Small Molecule API Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Small Molecule API Market, Segmentation By Manufacturer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Small Molecule API Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Small Molecule API Market

• 20.1. Spain Small Molecule API Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Small Molecule API Market, Segmentation By Manufacturer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Small Molecule API Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Small Molecule API Market

• 21.1. Eastern Europe Small Molecule API Market Overview
• 21.2. Eastern Europe Small Molecule API Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Small Molecule API Market, Segmentation By Manufacturer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Small Molecule API Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Small Molecule API Market

• 22.1. Russia Small Molecule API Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Small Molecule API Market, Segmentation By Manufacturer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Small Molecule API Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Small Molecule API Market

• 23.1. North America Small Molecule API Market Overview
• 23.2. North America Small Molecule API Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Small Molecule API Market, Segmentation By Manufacturer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Small Molecule API Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Small Molecule API Market

• 24.1. USA Small Molecule API Market Overview
• 24.2. USA Small Molecule API Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Small Molecule API Market, Segmentation By Manufacturer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Small Molecule API Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Small Molecule API Market

• 25.1. Canada Small Molecule API Market Overview
• 25.2. Canada Small Molecule API Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Small Molecule API Market, Segmentation By Manufacturer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Small Molecule API Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Small Molecule API Market

• 26.1. South America Small Molecule API Market Overview
• 26.2. South America Small Molecule API Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Small Molecule API Market, Segmentation By Manufacturer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Small Molecule API Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Small Molecule API Market

• 27.1. Brazil Small Molecule API Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Small Molecule API Market, Segmentation By Manufacturer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Small Molecule API Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Small Molecule API Market

• 28.1. Middle East Small Molecule API Market Overview
• 28.2. Middle East Small Molecule API Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Small Molecule API Market, Segmentation By Manufacturer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Small Molecule API Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Small Molecule API Market

• 29.1. Africa Small Molecule API Market Overview
• 29.2. Africa Small Molecule API Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Small Molecule API Market, Segmentation By Manufacturer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Small Molecule API Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Small Molecule API Market Competitive Landscape And Company Profiles

• 30.1. Small Molecule API Market Competitive Landscape
• 30.2. Small Molecule API Market Company Profiles
  • 30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Dr. Reddy's Laboratories Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Small Molecule API Market Other Major And Innovative Companies

• 31.1. Aurobindo Pharma
• 31.2. Sun Pharmaceutical Industries Ltd.
• 31.3. Teva Pharmaceutical Industries Ltd.
• 31.4. Viatris Inc.
• 31.5. Cambrex Corporation
• 31.6. Lonza Group AG
• 31.7. Siegfried Holding AG
• 31.8. AstraZeneca
• 31.9. F. Hoffmann-La Roche AG
• 31.10. Nanjing King-friend Biochemical Pharmaceutical Co. Ltd
• 31.11. Albany Molecular Research Inc.
• 31.12. BASF SE
• 31.13. Gilead Sciences Inc.
• 31.14. GlaxoSmithKline PLC
• 31.15. Johnson Matthey PLC

32. Global Small Molecule API Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Small Molecule API Market

34. Recent Developments In The Small Molecule API Market

35. Small Molecule API Market High Potential Countries, Segments and Strategies

• 35.1 Small Molecule API Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Small Molecule API Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Small Molecule API Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer